Expressed sequences as candidates for a novel tumor suppressor gene at band 13q14 in B-cell chronic lymphocytic leukemia and mantle cell lymphoma

被引:122
作者
Stilgenbauer, S
Nickolenko, J
Wilhelm, J
Wolf, S
Weitz, S
Döhner, K
Boehm, T
Döhner, H
Lichter, P
机构
[1] Deutsch Krebsforschungszentrum, Abt Org Komplexer Genome, D-69120 Heidelberg, Germany
[2] Med Klin & Poliklin 5, D-69115 Heidelberg, Germany
[3] Deutsch Krebsforschungszentrum, Abt Expt Therapie, D-69120 Heidelberg, Germany
关键词
deletion mapping; FISH; exon amplification; DIRVISH;
D O I
10.1038/sj.onc.1201764
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Deletions affecting the interval between the RB1 gene and marker D13S25 at band 13q14 are the most frequent genetic abnormalities of B-cell chronic lymphocytic leukemia (B-CLL) and indicate the presence of a novel tumor suppressor gene in this region. In the current study, a high resolution physical map of fragments spanning one megabasepair (Mb) of genomic DNA at the critical 13q14 segment was constructed. To define the minimal region of loss within the RB1 and D13S25 interval, we screened 322 B-CLLs for deletions at either of the two loci. Thirty mantle cell lymphomas (MCLs) were included in the analysis because we observed a 13q14 deletion pattern similar to B-CLL in this disease, The incidence of 13q14 deletions was 51% in B-CLL and 70% in MCL, respectively. No frequent loss of the BRCA2 gene at band 13q12 was found. Detailed deletion mapping at band 13q14 with probes from the RB1-D13S25 interval lead to the identification of a critical deletion region 400 kb in size. Within this region two segments were most frequently affected, one at D13S272 120 kb in size and another 240 kb distal of D13S272 80 kb in size. From these two segments expressed sequences were identified as candidates for the putative 13q14 tumor suppressor gene involved in the pathogenesis of B-CLL and MCL.
引用
收藏
页码:1891 / 1897
页数:7
相关论文
共 27 条
  • [1] ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
  • [2] [Anonymous], [No title captured]
  • [3] A METHOD FOR THE RAPID SEQUENCE-INDEPENDENT AMPLIFICATION OF MICRODISSECTED CHROMOSOMAL MATERIAL
    BOHLANDER, SK
    ESPINOSA, R
    LEBEAU, MM
    ROWLEY, JD
    DIAZ, MO
    [J]. GENOMICS, 1992, 13 (04) : 1322 - 1324
  • [4] EVIDENCE FOR A NEW TUMOR SUPPRESSOR LOCUS (DBM) IN HUMAN B-CELL NEOPLASIA TELOMERIC TO THE RETINOBLASTOMA GENE
    BROWN, AG
    ROSS, FM
    DUNNE, EM
    STEEL, CM
    WEIRTHOMPSON, EM
    [J]. NATURE GENETICS, 1993, 3 (01) : 67 - 72
  • [5] Minimal region of loss at 13q14 in B-cell chronic lymphocytic leukemia
    Bullrich, F
    Veronese, ML
    Kitada, S
    Jurlander, J
    Caligiuri, MA
    Reed, JC
    Croce, CM
    [J]. BLOOD, 1996, 88 (08) : 3109 - 3115
  • [6] CHAPMAN RM, 1994, ONCOGENE, V9, P1289
  • [7] National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment
    Cheson, BD
    Bennett, JM
    Grever, M
    Kay, N
    Keating, MJ
    OBrien, S
    Rai, KR
    [J]. BLOOD, 1996, 87 (12) : 4990 - 4997
  • [8] DEVILDER MC, 1995, CANCER RES, V55, P1355
  • [9] 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis
    Dohner, H
    Stilgenbauer, S
    James, MR
    Benner, A
    Weilguni, T
    Bentz, M
    Fischer, K
    Hunstein, W
    Lichter, P
    [J]. BLOOD, 1997, 89 (07) : 2516 - 2522
  • [10] DOHNER H, 1997, LEUKEMIA S2, V11, P19